iDharma is an independent AI audit company. It reviews the AI systems organizations run and delivers a verified, standards-based report on whether their AI is accurate, fair, secure, and compliant — mapped to the EU AI Act, NIST AI RMF, and ISO/IEC 42001.

What does an iDharma AI audit cover?

An iDharma audit examines four dimensions of a live AI system — accuracy, fairness, security, and compliance — and returns a rating per dimension, evidence-backed findings, and a prioritized remediation roadmap. The scope is agreed and approved with you before any payment.

How is iDharma independent?

iDharma audits AI systems it did not build and holds no stake in the tools it reviews, so its findings are defensible to a board, a customer, or a regulator. An audit is a methodology-backed review — not a certification or a warranty.

Which standards does iDharma audit against?

iDharma maps findings to recognized frameworks including the EU AI Act, the NIST AI Risk Management Framework, ISO/IEC 42001, HIPAA, SOC 2, and India's DPDP Act — so every finding traces to a clause, not an opinion.

How do I request an AI audit?

Tell iDharma about your AI system through the Request an AI Audit form. Scope, timeline, and price are agreed up front, and nothing is charged until you approve the scope.

AI Insights for HEALTHCARE

Healthcare AI Compliance: Clinical Systems & High-Risk AI

Clinical decision support, diagnostic tools, and patient-facing AI are explicitly high-risk under the EU AI Act — and US regulators are signalling enforcement is next. Here is what preparing looks like.

Annex III

Healthcare AI systems directly named as high-risk under the EU AI Act

Obligations from Aug 2026

$45M

EU AI hiring platform fine — human-oversight failures directly transferable to clinical AI

2026 precedent

Jan 2026

Texas TRAIGA healthcare-AI provisions effective — verify current scope before relying on this date

State-level obligation

AI diagnostic tools, triage systems, and clinical decision support fall directly within the EU AI Act's high-risk classification (Annex III). FDA SaMD guidance and HIPAA data governance add a second and third layer for US-market deployments. The pre-enforcement window for healthcare AI is open — and will not stay open indefinitely.

⭐ Featured Insight

★ Featured STANDARDS EXPLAINED

8 min read

🏥 Healthcare

AI Compliance for Healthcare Providers: What Actually Applies

Four regimes reach clinical AI, and they ask different questions. What each one wants a provider to be able to show — and the two places health systems are most often caught short.

📚 All Healthcare Insights

🔗 Explore Other Domains

🌐 General Insights → 🏦 Fintech Insights → 📌 Finance Insights → 🛡️ Insurance Insights → 📋 All Insights →